NCT03795142View on ClinicalTrials.gov

A First-time-in-human Study of BGB149

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

BGB149

Single Ascending Dose

BIOLOGICAL

Placebo

Matching placebo

Trial Locations (1)

HA1 3UJ

Parexel Northwick Park, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

BerGenBio ASA

INDUSTRY

NCT03795142 - A First-time-in-human Study of BGB149 | Biotech Hunter | Biotech Hunter